Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
Clinical trial NCT04278417 · COMPLETED
Trial details
- NCT number
- NCT04278417
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2023-10-30
- Enrollment
- 689
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.